Efficacy and safety of fruquintinib plus sintilimab in third-line treatment of metastatic colorectal cancer: A single-center experience

Figure 3 Imaging. A: Patient 1, baseline; B: Patient 1, after 3 cycles; C: Patient 2, baseline; D: Patient 2, after 4 cycles; E: Patient 3, baseline; F: Patient 3, after 3 cycles; G: Patient 4, baseline; H: Patient 4, after 6 cycles; I: Patient 5, baseline; J: Patient 5, after 12 cycles; K: Patient 6, baseline; L: Patient 6, after 2 cycles. Orange arrows indicate the main lesions. Baseline refers to imaging at initiation of fruquintinib combined with sintilimab.